Accordingly, blocking NK1R using aprepitant improves cardiac functions in erlotinib-treated rats by reducing erlotinib-induced hypomagnesemia and subsequent SP elevation, thereby, inhibiting SP-induced oxidative/inflammation stress [48]. This evidence concerns the gene TACR1 and Hypomagnesemia.